RNA disruption indicates CHOP therapy efficacy in canine lymphoma

Amadeo M Parissenti1,2, Laura B Pritzker3, Baoqing Guo4

  • 1Departments of Biology, Chemistry and Biochemistry, Laurentian University, 935 Ramsey Lake Rd., Sudbury, ON, P3E 2C6, Canada. aparissenti@rnadiagnostics.com.

BMC Veterinary Research
|December 18, 2019
PubMed
Summary

Assessing RNA disruption during chemotherapy for canine lymphoma can predict treatment success. An increased RNA disruption index indicates longer remission, potentially improving treatment strategies for dogs with lymphoma.